Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12879-017-2831-9
Published Online: 2017-11-16
Published Print: 2017-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Gianotti, Nicola http://orcid.org/0000-0002-7182-5080
Poli, Andrea
Nozza, Silvia
Galli, Laura
Galizzi, Nadia
Ripa, Marco
Merli, Marco
Carbone, Alessia
Spagnuolo, Vincenzo
Lazzarin, Adriano
Castagna, Antonella